Sr. Director, R&D Technology, PLM, Othopedics

Johnson & Johnson announced plans to separate our Orthopaedics business to establish a standalone Orthopaedics company, operating as De. Puy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject Technology, Director, R&D, Product Development, Continuous Improvement, Leadership, Manufacturing